Urology · Wichita, KS
NPI
1508985417
Since 2007
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2626 N Webb Rd
Wichita, KS, 67226
Phone (316) 636-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$734K
25,582 services
Medicare patients, 2024
1,497
Average age 75
Drug cost, 2024
$13.0M
3,800 prescriptions
Company payments, 2025
$57K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tim A Richardson was code J0897 (injection, denosumab, 1 mg), 8,460 times for 66 patients. In total Tim A Richardson billed 25,582 services in 125 codes, and Medicare paid $734K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 8,460 | 66 | $20.51 | $174K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 7,425 | 70 | $0.10 | $750 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,159 | 21 | $2.26 | $2,614 |
| 99214 Office E&M - Established | Office | 742 | 570 | $82.74 | $61K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 360 | 73 | $129.98 | $47K |
| 99204 Office E&M - New | Office | 300 | 300 | $110.08 | $33K |
| 81001 Clinical Chemistry | Office | 284 | 237 | $3.08 | $875 |
| 81003 Clinical Chemistry | Office | 274 | 251 | $2.19 | $601 |
| 36415 Venipuncture Blood Collection | Office | 261 | 254 | $8.65 | $2,258 |
| 99213 Office E&M - Established | Office | 242 | 226 | $55.03 | $13K |
| 84153 Clinical Chemistry | Office | 222 | 215 | $17.97 | $3,989 |
| 51798 Ultrasound - Nonspecific | Office | 213 | 186 | $7.37 | $1,570 |
| 52000 Cystourethroscopy | Office | 186 | 163 | $158.36 | $29K |
| 96402 Chemotherapy Administration | Office | 124 | 81 | $24.41 | $3,026 |
| 80047 Clinical Chemistry | Office | 117 | 112 | $13.36 | $1,564 |
By year: 2022 $756K for 26,907 services; 2023 $773K for 28,834 services; 2024 $734K for 25,582 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 284 | 237 | $3.08 | $875 |
| 81003 Clinical Chemistry | 274 | 251 | $2.19 | $601 |
| 36415 Venipuncture Blood Collection | 261 | 254 | $8.65 | $2,258 |
| 84153 Clinical Chemistry | 222 | 215 | $17.97 | $3,989 |
| 80047 Clinical Chemistry | 117 | 112 | $13.36 | $1,564 |
| G0416 Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 53 | 53 | $131.59 | $6,974 |
| 84403 Clinical Chemistry | 51 | 49 | $25.03 | $1,277 |
Medicare prescription drug claims, 2024
In 2024, the drug Tim A Richardson prescribed most often to Medicare patients was Tamsulosin Hcl, with 850 prescriptions and refills. In total Tim A Richardson wrote 3,800 Medicare prescriptions that cost $13.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 850 | 1,981 | 260 | $8,251 |
| Erleada Apalutamide | 365 | 365 | 40 | $5.3M |
| Orgovyx Relugolix | 361 | 361 | 49 | $950K |
| Finasteride Generic | 277 | 736 | 84 | $2,200 |
| Xtandi Enzalutamide | 242 | 242 | 31 | $3.3M |
| Nubeqa Darolutamide | 218 | 218 | 27 | $2.9M |
| Myrbetriq Mirabegron | 170 | 230 | 42 | $105K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 142 | 142 | 129 | $972 |
| Solifenacin Succinate Generic | 99 | 170 | 37 | $3,678 |
| Prednisone Generic | 87 | 99 | 20 | $734 |
| Gemtesa Vibegron | 84 | 102 | 19 | $49K |
| Oxybutynin Chloride Generic | 69 | 162 | 32 | $1,530 |
| Methenamine Hippurate Generic | 69 | 155 | 20 | $6,521 |
| Abiraterone Acetate Generic | 58 | 58 | 11 | $107K |
| Megestrol Acetate Generic | 55 | 87 | 16 | $1,286 |
Brand drugs: - claims; generic drugs: 2,291 claims; opioid claims: 173.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tim A Richardson $57K ($57K in general payments such as food, travel and fees) from 26 companies. The largest payer was Janssen Biotech, Inc. with $20K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 26 | $20K |
| Astellas Pharma US Inc 4503.T | 9 | $8,245 |
| Pfizer Inc. PFE | 11 | $5,623 |
| Merck Sharp & Dohme LLC MRK | 6 | $5,282 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $4,691 |
| Dendreon Pharmaceuticals LLC | 4 | $3,864 |
| Ferring Pharmaceuticals Inc. | 1 | $2,850 |
| Immunitybio, Inc. IBRX | 4 | $2,779 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $1,556 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $1,555 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.